⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15063623 | 0.78 | — | — | |
| SCHEMBL15063979 | 0.78 | — | — | |
| SCHEMBL161217 | 0.76 | CA2 (0.36) | — | |
| SCHEMBL745940 | 0.74 | — | — | |
| SCHEMBL315488 | 0.74 | KDM4E (0.35) | — | |
| SCHEMBL29212774 | 0.74 | TUBB1 (0.31) | — | |
| SCHEMBL5653822 | 0.70 | ALDH1A1 (0.39) | — | |
| SCHEMBL2306800 | 0.70 | TUBB1 (0.31) | — | |
| SCHEMBL7679493 | 0.70 | ACHE (0.34) | — | |
| SCHEMBL7820403 | 0.69 | PDE4B (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4759762-B2 | — | — | 2011-08-31 | — | — | JP | claimed |
| EP-0891331-B1 | N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY | VERTEX PHARMA (US) | 2003-10-01 | — | — | EP | claimed |
| EP-0891331-A1 | N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY | Vertex Pharmaceuticals Incorporated (US) | 1999-01-20 | — | — | EP | claimed |
| US-5717092-A | Compounds with improved multi-drug resistance activity | VERTEX PHARMACEUTICALS INC. (US) | 1998-02-10 | — | — | US | claimed |
| WO-1997036869-A1 | N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1997-10-09 | — | — | WO | claimed |
| US-20240044876-A1 | IDENTIFYING NEW THERAPEUTIC AGENTS | WARP DRIVE BIO, INC. | 2024-02-08 | — | — | US | disclosed |
| WO-2023190912-A1 | POLAR-GROUP-CONTAINING OLEFIN COPOLYMER AND METHOD FOR PRODUCING SAME | 日本ポリケム株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3978537-B1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | UNIV TOKYO (JP) | 2023-09-13 | — | — | EP | disclosed |
| US-11644460-B2 | Identifying new therapeutic agents | Revolution Medicines, Inc. (US) | 2023-05-09 | — | — | US | disclosed |
| WO-2023033030-A1 | POLAR-GROUP-CONTAINING OLEFIN COPOLYMER AND METHOD FOR PRODUCING SAME | 国立大学法人 東京大学 | 2023-03-09 | — | — | WO | disclosed |
| US-20220220239-A1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | THE UNIVERSITY OF TOKYO (JP) | 2022-07-14 | — | — | US | disclosed |
| CN-113874402-A | Polar group-containing olefin copolymer | 国立大学法人东京大学 | 2021-12-31 | — | — | CN | disclosed |
| EP-0891331-B1 | N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY | VERTEX PHARMA (US) | 2003-10-01 | — | — | EP | disclosed |
| US-5935954-A | TREATING THE PATIENT SUFFERING FROM PARKINSON'S DISEASE, ALZHIMER'S DISEASE, STROKE AND ISCHEMIA ASSOCIATED WITH STROKE, NEURAL PAROPATHY, SCIATIC CRUSH, SPINAL CORD INJURY OR FACIAL NERVE CRASH | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1999-08-10 | — | — | US | disclosed |
| EP-0891331-A1 | N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY | Vertex Pharmaceuticals Incorporated (US) | 1999-01-20 | — | — | EP | disclosed |
| US-5717092-A | Compounds with improved multi-drug resistance activity | VERTEX PHARMACEUTICALS INC. (US) | 1998-02-10 | — | — | US | disclosed |
| WO-1997036869-A1 | N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1997-10-09 | — | — | WO | disclosed |
| EP-0051273-B1 | TRIALKYLAMINE/SULFUR DIOXIDE CATALYZED SULFENYLATION OF CARBAMATES | FMC Corporation (US) | 1985-01-02 | — | — | EP | disclosed |
| EP-0051273-A1 | Trialkylamine/sulfur dioxide catalyzed sulfenylation of carbamates | FMC Corporation (US) | 1982-05-12 | — | — | EP | disclosed |
| US-4329293-A | Trialkylamine/sulfur dioxide catalyzed sulfenylation of carbamates | FMC CORPORATION (US) | 1982-05-11 | — | — | US | disclosed |